Kimia Bioscien.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE285U01025
  • NSEID:
  • BSEID: 530313
INR
30.41
-0.66 (-2.12%)
BSENSE

Nov 20

BSE+NSE Vol: 1.32 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Makers Labs.
Achyut Healthcar
Kimia Bioscien.
Medico Remedies
Quest Laborato.
Balaxi Pharma
Syschem (India)
Auro Labs.
Asston Pharmaceu
Guj. Inject(Ker)
Himalaya Nutrave
Why is Kimia Biosciences Ltd ?
1
High Debt Company with a Debt to Equity ratio (avg) at 12.05 times
  • Poor long term growth as Net Sales has grown by an annual rate of -4.53% and Operating profit at 65.08% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 12.05 times
  • The company has been able to generate a Return on Capital Employed (avg) of 12.08% signifying low profitability per unit of total capital (equity and debt)
2
Flat results in Sep 26
  • OPERATING CF(Y) Lowest at Rs 10.84 Cr
  • NET SALES(9M) At Rs 74.73 cr has Grown at -22.01%
3
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from Sideways on 20-Nov-26
  • The stocks MACD and KST technical factors are also Bearish
4
With ROCE of 28.4, it has a Attractive valuation with a 3.4 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -10.82%, its profits have risen by 4.7% ; the PEG ratio of the company is 3.6
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Kimia Bioscien. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Kimia Bioscien. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Kimia Bioscien.
-10.82%
-0.17
64.07%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-4.53%
EBIT Growth (5y)
65.08%
EBIT to Interest (avg)
0.97
Debt to EBITDA (avg)
1.08
Net Debt to Equity (avg)
1.91
Sales to Capital Employed (avg)
2.36
Tax Ratio
11.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.38%
ROCE (avg)
7.35%
ROE (avg)
27.67%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
17
Industry P/E
40
Price to Book Value
8.12
EV to EBIT
14.93
EV to EBITDA
11.00
EV to Capital Employed
3.45
EV to Sales
1.70
PEG Ratio
3.62
Dividend Yield
NA
ROCE (Latest)
28.37%
ROE (Latest)
48.31%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
PBT LESS OI(Q)

At Rs 2.40 cr has Grown at 29.9% (vs previous 4Q average

PAT(Q)

At Rs 2.39 cr has Grown at 33.0% (vs previous 4Q average

-4What is not working for the Company
OPERATING CF(Y)

Lowest at Rs 10.84 Cr

NET SALES(9M)

At Rs 74.73 cr has Grown at -22.01%

Loading Valuation Snapshot...
Here's what is working for Kimia Bioscien.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 2.40 cr has Grown at 29.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1.85 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 2.39 cr has Grown at 33.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1.80 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Kimia Bioscien.
Net Sales - Nine Monthly
At Rs 74.73 cr has Grown at -22.01%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Cash Flow - Annually
Lowest at Rs 10.84 Cr
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (Rs Cr)